Juan Carlos Galofre Ferrater-rekin lankidetzan egindako argitalpenak (7)

2024

  1. Tracking dynamic evolution of low- and intermediate-risk differentiated thyroid cancer: Identification of individuals at risk of recurrence

    Clinical Endocrinology, Vol. 101, Núm. 3, pp. 286-294

2023

  1. Clinical implications of changing thyroglobulin and antithyroglobulin antibodies analytical methods in the follow-up of patients with differentiated thyroid carcinoma

    Clinica Chimica Acta, Vol. 548

2022

  1. Questionable High Free T4 Concentrations: When Confirming against an Alternative Method Is Not Enough

    Clinical chemistry, Vol. 68, Núm. 9, pp. 1128-1132

2020

  1. Utilidad del test de TSH recombinante en el seguimiento de pacientes con cáncer diferenciado de tiroides según los resultados de tiroglobulina basal

    Advances in Laboratory Medicine, Vol. 1, Núm. 1

  2. Utility of recombinant human TSH stimulation test in the follow-up of patients with differentiated thyroid cancer depending on basal thyroglobulin results

    Advances in Laboratory Medicine, Vol. 1, Núm. 1

2019

  1. Circulating concentrations of GDF11 are positively associated with TSH levels in humans

    Journal of Clinical Medicine, Vol. 8, Núm. 6

2008

  1. Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders

    Clinical Biochemistry, Vol. 41, Núm. 9, pp. 688-692